BPC-157 (Body Protection Compound-157) is a synthetic peptide that has been widely studied in laboratory research involving tissue biology, regenerative science, vascular biology, and gastrointestinal research
ASPEN is a multinational, randomized, double-blind, placebo-controlled, parallel-group study that is evaluating the frequency and severity of exacerbations as well as the safety and tolerability of long-term (52-week) treatment with brensocatib compared with placebo in patients with non-cystic fibrosis bronchiectasis
What NAPQI does: Directly binds to and damages cellular proteins Depletes glutathione rapidly Generates oxidative stress which damages DNA Triggers cell death Damages mitochondria, disrupting energy production NAPQI crosses the placenta and depletes fetal brain glutathione at doses below those causing maternal liver toxicity
Vineeta Pathak two of Indias most trusted names in aesthetic care personally design and perform each glutathione IV drip session
255 Methionine adenosyl-transferase 1 (MAT1) synthesizes SAM in the liver
